上市公司密集设立并购基金，又一家LP入局

Core Viewpoint - The article discusses the establishment of a new 500 million RMB industrial merger fund by He Yuan Biotechnology, highlighting the growing trend of merger funds in the Chinese market and the supportive policies driving this growth [2][3][8]. Group 1: Fund Establishment - He Yuan Biotechnology announced its plan to co-establish the He Yuan Hongsheng Industrial Investment Fund with Shanghai Hongsheng Junhao Equity Investment Fund Management Co., Ltd. and other partners, with a total fund size of 500 million RMB [5]. - He Yuan Biotechnology will contribute up to 100 million RMB as a limited partner (LP), accounting for 20% of the fund, while the general partners will contribute 5 million RMB, representing 1% [5]. - The fund's duration is set for 8 years, with the first 4 years designated for investment and the latter 4 years for exit [5]. Group 2: Investment Focus - The fund will focus on the cell and gene therapy (CGT) industry chain and related upstream and downstream fields, aiming to provide systematic and efficient tools for industrial integration [6]. - He Yuan Biotechnology aims to leverage Hongsheng Junhao's resources and advantages in equity investment to create a "dedicated strategic platform" around its industrial ecosystem [6]. Group 3: Market Trends - The establishment of this fund reflects a broader trend in the merger fund industry, which has seen significant growth since 2025, driven by supportive policies such as the "New National Nine Articles" and "Merger Six Articles" [8]. - In 2025, 305 listed companies participated in the establishment of 321 industrial merger funds, with a total fundraising scale of approximately 297.51 billion RMB, showing a notable increase from 2024 [8]. - The merger and acquisition (M&A) market is experiencing a surge, with significant transactions across various sectors, including consumer goods, manufacturing, resources, and biomedicine [9]. Group 4: Policy Support - The Chinese government is enhancing support for the merger fund sector, with plans to establish a national-level merger fund and promote innovation and entrepreneurship [10]. - New merger funds are increasingly concentrated in strategic sectors such as advanced manufacturing, healthcare, artificial intelligence, automotive, new materials, and semiconductors, indicating their role in implementing national industrial policies [10]. - In 2025, the transaction volume of China's M&A market exceeded 400 billion USD, marking a 47% year-on-year increase, with expectations for continued activity in high-tech and new energy sectors in 2026 [10].